Portola Pharmaceuticals, Inc. (PTLA): Price and Financial Metrics

Portola Pharmaceuticals, Inc. (PTLA): $18.03

0.04 (+0.22%)

POWR Rating

Component Grades













Add PTLA to Watchlist
Sign Up

Industry: Biotech



in industry

PTLA Stock Price Chart Interactive Chart >

Price chart for PTLA

PTLA Price/Volume Stats

Current price $18.03 52-week high $31.73
Prev. close $17.99 52-week low $5.31
Day low $17.99 Volume 8,094,400
Day high $18.07 Avg. volume 3,172,176
50-day MA $15.97 Dividend yield N/A
200-day MA $18.62 Market Cap 1.42B

Portola Pharmaceuticals, Inc. (PTLA) Company Bio

Portola Pharmaceuticals is a biopharmaceutical company developing product candidates that could significantly advance the fields of thrombosis and other hematologic diseases. The company was founded in 2003 and is based in South San Francisco, California.

PTLA Latest News Stream

Event/Time News Detail
Loading, please wait...

PTLA Latest Social Stream

Loading social stream, please wait...

View Full PTLA Social Stream

Latest PTLA News From Around the Web

Below are the latest news stories about Portola Pharmaceuticals Inc that investors may wish to consider to help them evaluate PTLA as an investment opportunity.

Portola Pharmaceuticals Inc (PTLA): Hedge Funds Are Cashing Out

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each […]

Yahoo | June 24, 2020

Rigrodsky & Long, P.A. Files Class Action Suit Against Portola Pharmaceuticals, Inc.

WILMINGTON, Del., June 17, 2020 -- Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of.

Yahoo | June 18, 2020

SHAREHOLDER ALERT: WeissLaw LLP Reminds QUMU, TCO, PTLA, and WLTW Shareholders About Its Ongoing Investigations

NEW YORK, June 05, 2020 -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice.

Yahoo | June 5, 2020

KLXE, TORC, TERP, and PTLA SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

WILMINGTON, Del., June 04, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: KLX Energy Services Holdings, Inc. (NASDAQ GS: KLXE) regarding possible.

Yahoo | June 4, 2020

Lifshitz Law Firm, P.C. Announces Investigation of Franklin Financial Network, Inc., Mobile Mini, Inc., Portola Pharmaceuticals, Inc., resTORbio, Inc., Stemline Therapeutics, Inc., Taubman Centers, Inc. and Willis Towers Watson Public Limited Company and Wright Medical Group N.V.

Franklin Financial Network, Inc. (FSB)

Yahoo | May 28, 2020

Read More 'PTLA' Stories Here

PTLA Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year 40.97%
5-year -65.60%
2022 N/A
2021 N/A
2020 0.00%
2019 22.34%
2018 -59.90%

Continue Researching PTLA

Here are a few links from around the web to help you further your research on Portola Pharmaceuticals Inc's stock as an investment opportunity:

Portola Pharmaceuticals Inc (PTLA) Stock Price | Nasdaq
Portola Pharmaceuticals Inc (PTLA) Stock Quote, History and News - Yahoo Finance
Portola Pharmaceuticals Inc (PTLA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7024 seconds.